Paper21551958
Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study.
Jeong SY and 9 others. Endocr J, 2011. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study. Papers, record 21551958. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21551958
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Iodine Radioisotopes | Major topic |
| Symporters | Major topic |
| Thyroid Gland | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Diagnostic Imaging | |
| Female | |
| Humans | |
| Luminescence | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Microscopy, Confocal | |
| Pilot Projects | |
| Radionuclide Imaging | |
| Specific Pathogen-Free Organisms | |
| Transplantation, Heterologous | |
| Sodium-Iodide Symporters |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42028169 | Review of Cherenkov imaging technology advances in radiotherapy: single-photon-level imaging in high ambient light and radiation backgrounds. | Biophotonics Discov | 2024 | https://conductscience.org/library/papers/42028169 | PubMed |
| 33569663 | Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA. | EJNMMI Res | 2021 | https://conductscience.org/library/papers/33569663 | PubMed |
| 30779286 | Radionuclide-Activated Nanomaterials and Their Biomedical Applications. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/30779286 | PubMed |
| 29951528 | Recent Development of Nuclear Molecular Imaging in Thyroid Cancer. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29951528 | PubMed |
| 29858793 | Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29858793 | PubMed |
| 29258188 | Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29258188 | PubMed |
| 28720762 | Quantitative Measurement of the Thyroid Uptake Function of Mouse by Cerenkov Luminescence Imaging. | Sci Rep | 2017 | https://conductscience.org/library/papers/28720762 | PubMed |
| 28283990 | Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences. | EJNMMI Phys | 2017 | https://conductscience.org/library/papers/28283990 | PubMed |
| 25577521 | Feasibility study of novel endoscopic Cerenkov luminescence imaging system in detecting and quantifying gastrointestinal disease: first human results. | Eur Radiol | 2015 | https://conductscience.org/library/papers/25577521 | PubMed |
| 25287690 | Cerenkov imaging. | Adv Cancer Res | 2014 | https://conductscience.org/library/papers/25287690 | PubMed |
| 23928799 | Optimization of microfluidic PET tracer synthesis with Cerenkov imaging. | Analyst | 2013 | https://conductscience.org/library/papers/23928799 | PubMed |
| 23133811 | Cerenkov imaging - a new modality for molecular imaging. | Am J Nucl Med Mol Imaging | 2012 | https://conductscience.org/library/papers/23133811 | PubMed |
| 22904353 | Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. | J Nucl Med | 2012 | https://conductscience.org/library/papers/22904353 | PubMed |
| 22539935 | Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back. | Theranostics | 2012 | https://conductscience.org/library/papers/22539935 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC5A5 | 6528 | PubTator's text mining | https://conductscience.org/library/genes/6528 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21551958
GET https://conductscience.org/api/papers/v1/21551958/authors